Search Results - "Lilly, E. A."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Candida albicans forms biofilms on the vaginal mucosa by HARRIOTT, M. M, LILLY, E. A, RODRIGUEZ, T. E, FIDEL, P. L, NOVERR, M. C

    “…Current understanding of resistance and susceptibility to vulvovaginal candidiasis challenges existing paradigms of host defence against fungal infection…”
    Get full text
    Journal Article
  2. 2

    Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis by Garvey, E P, Hoekstra, W J, Schotzinger, R J, Sobel, J D, Lilly, E A, Fidel, Jr, P L

    Published in Antimicrobial agents and chemotherapy (01-09-2015)
    “…Vulvovaginal candidiasis (VVC) and recurrent VVC (RVVC) remain major health problems for women. VT-1161, a novel fungal CYP51 inhibitor which has potent…”
    Get full text
    Journal Article
  3. 3

    Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety by Lilly, E.A., Yano, J., Fidel Jr, P.L.

    Published in Molecular oral microbiology (01-08-2010)
    “…Summary Innate and adaptive immunity are considered critical to protection against mucosal candidal infections. Among innate anti‐Candida mechanisms, oral and…”
    Get full text
    Journal Article
  4. 4

    CD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis by Quimby, K, Lilly, EA, Zacharek, M, McNulty, K, Leigh, JE, Vazquez, JE, Fidel Jr, PL

    Published in Oral diseases (01-03-2012)
    “…Oral Diseases (2012) 18, 153–161 Background:  Oropharyngeal candidiasis (OPC) is the most common oral infection in HIV+ persons. Previous studies suggest a…”
    Get full text
    Journal Article
  5. 5

    Fabrication of a multi-applicable removable intraoral denture system for rodent research by LEE, H., YU, A., JOHNSON, C. C., LILLY, E. A., NOVERR, M. C., FIDEL JR, P. L.

    Published in Journal of oral rehabilitation (01-09-2011)
    “…Summary  The objective was to engineer an inexpensive intraoral removable denture system for rodents that can be utilised in numerous oral health research…”
    Get full text
    Journal Article
  6. 6

    Chemokine receptor expression in HIV-positive persons with oropharyngeal candidiasis by Lilly, EA, Leigh, JE, McNulty, KM, Joseph, SH, Mercante, DE, Fidel Jr, PL

    Published in Oral diseases (01-09-2006)
    “…Objective:  In HIV+ persons with reduced CD4+ T cells, oropharyngeal candidiasis (OPC) is often associated with the accumulation of CD8+ T cells at the…”
    Get full text
    Journal Article
  7. 7

    Tissue-Associated Cytokine Expression in HIV-Positive Persons with Oropharyngeal Candidiasis by Lilly, Elizabeth A., Hart, Darrenn J., Leigh, Janet E., Hager, Shannon, McNulty, Kelly M., Mercante, Donald E., Fidel, Paul L

    Published in The Journal of infectious diseases (01-08-2004)
    “…Oropharyngeal candidiasis (OPC), caused by Candida albicanSy is the most common infection in human immunodeficiency virus (HlV)-positive persons. Although CD4+…”
    Get full text
    Journal Article
  8. 8

    Candida-induced oral epithelial cell responses by Lilly, E A, Leigh, J E, Joseph, S H, Fidel, Jr, P L

    Published in Mycopathologia (1975) (01-07-2006)
    “…Oropharyngeal candidiasis (OPC), caused by Candida albicans, is the most common oral infection in HIV(+) persons. Oral epithelial cells are considered…”
    Get full text
    Journal Article
  9. 9

    Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells by Yano, J., Lilly, E. A., Steele, C., Fortenberry, D., Fidel Jr, P. L.

    Published in Oral microbiology and immunology (01-08-2005)
    “…Background:  Candida albicans is the causative agent of oral and vaginal candidiasis. Innate host defenses against C. albicans are important against each…”
    Get full text
    Journal Article
  10. 10

    Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions by Lilly, E. A., Cameron, J. E., Shetty, K. V., Leigh, J. E., Hager, S., McNulty, K. M., Cheeks, C., Hagensee, M. E., Fidel Jr, P. L.

    Published in Oral microbiology and immunology (01-06-2005)
    “…Background:  Oral warts, caused by human papillomavirus (HPV), and oral hairy leukoplakia (OHL) caused by Epstein‐Barr virus (EBV), are common oral…”
    Get full text
    Journal Article
  11. 11

    Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions by Lilly, Elizabeth A., Shetty, Kishore V., Leigh, Janet E., Cheeks, Cheryl, Fidel, Paul L.

    Published in Medical mycology (Oxford) (01-09-2005)
    “…Anti-Candida activity by oral epithelial cells is considered one of several innate mucosal defense mechanisms against oropharyngeal candidiasis (OPC). OPC is…”
    Get full text
    Journal Article
  12. 12

    Assessment of the association between HIV viral load and CD4 cell count on the occurrence of oropharyngeal candidiasis in HIV-infected patients by MERCANTE, Donald E, LEIGH, Janet E, LILLY, Elizabeth A, MCNULTY, Kelly, FIDEL, Paul L

    “…Oropharyngeal candidiasis (OPC) is the most frequently observed oral infection in HIV-infected individuals. Historically, lower CD4 counts have been associated…”
    Get full text
    Journal Article
  13. 13

    ORIGINAL ARTICLE: Chemokine receptor expression in HIV-positive persons with oropharyngeal candidiasis by Lilly, E A, Leigh, JE, McNulty, K M, Joseph, SH, Mercante, DE, Fidel, P L

    Published in Oral diseases (01-09-2006)
    “…Objective:In HIV+ persons with reduced CD4 super(+) T cells, oropharyngeal candidiasis (OPC) is often associated with the accumulation of CD8 super(+) T cells…”
    Get full text
    Journal Article